Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir and cefaclor for mild influenza pneumonia
ChiCTR1900021886Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oseltamivir and cefaclor in influenza pneumonia (4 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Total effect. Started Jun 2018; status: recruiting.
02
Drugs
oseltamivircefaclor
03
Conditions
influenza pneumonia
Beyond the preview
Go deeper on ChiCTR1900021886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021886.